BioLife Solutions, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+198.8% +$3M
$5M
Free Cash Flow↓-49.1% -$807K
$838K
Investing Cash Flow↓-98.5% -$73M
$1M
Financing Cash Flow↓-214.3% -$2M
$-3M
Capex
$4M
Acquisitions
—
Stock-Based Comp↓-33.8% -$4M
$7M
Debt Issued
—
Debt Repaid
—
D&A↓-72.1% -$676K
$261K
SBC Allocated Expense↓-49.7% -$5M
$5M
SBC Unrecognized Cost
—